Document is current
Any future updates will be listed below
-
Authors
Hori, Hitomi
Kaneko, Shinji
Fujita, Masaya
Nagai, Shin
Ito, Ryota
Shirai, Yoshinori
Adachi, Kentaro
Suzuki, Noriyuki
Suzuki, Junya
Kondo, Kiyota
Yamauchi, Ryota
Haga, Tomoaki
Tatami, Yosuke
Ohashi, Taiki
Kubota, Ryuji
Shinoda, Masanori
Tanaka, Akihito
Inden, Yasuya
Murohara, Toyoaki
- License Information
-
More Information
Article History
Received: 16 June 2022
Accepted: 22 September 2022
First Online: 6 October 2022
Declarations
:
: This study was approved by the local Ethics Committee. (2021-ST07).
: Written informed consent was waived in this study because of retrospective design.
: Toyoaki Murohara received lecture fees from Bayer Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Pfizer Japan Inc., Sanofi-aventis K. K., and Takeda Pharmaceutical Co., Ltd. Toyoaki Murohara received unrestricted research grant for Department of Cardiology, Nagoya University Graduate School of Medicine from Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Otsuka Pharma Ltd., Pfizer Japan Inc., Sanofi-aventis K. K., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
